B Cell News and Research

RSS

Scientists discover how polyketides form their ringlike shape

Many top-selling drugs used to treat cancer and lower cholesterol are made from organic compounds called polyketides, which are found in nature but historically difficult for chemists to alter and reproduce in large quantities.

2 Apr 2008

Older corneas suitable for transplantation

The age pool of corneas for transplant should be expanded to include donors up to 75 years of age, based on findings from a study funded by the National Eye Institute (NEI), one of the National Institutes of Health (NIH).

2 Apr 2008

Newly identified gene may prompt pancreas cells to form

Before a pancreas is a pancreas, it?s part of the endoderm, one of three layers of cells in a developing embryo that eventually form its organs.

2 Apr 2008

The mysterious link between summer birthdates and myopia

Do corneas from older donors meet quality standards for transplant surgery? These are among the topics explored in the April 2008 issue of Ophthalmology, the journal of the American Academy of Ophthalmology.

2 Apr 2008

Bosentan drugs offers new approach to limiting organ damage in sickle cell disease

Sickle cell disease (SCD) is so called because of the abnormal sickle shape of the red blood cells in individuals with this blood disorder.

2 Apr 2008

Immune system needs food to function properly

Researchers studying deer mice have discovered evidence to support what mothers everywhere have long suspected: the immune system needs food to function properly.

2 Apr 2008

Dallas area cornea shortages could benefit from national study

Surgeons and patients from UT Southwestern Medical Center and UT Southwestern Transplant Services Center joined in a landmark study showing that corneas from older donors are as successful for transplants after five years as is tissue from younger donors, allowing possible expansion of the donor pool.

2 Apr 2008

Tai Chi improves control of type 2 diabetes

Tai Chi exercises can improve the control of type 2 diabetes, suggests a small study, published ahead of print in the British Journal of Sports Medicine.

1 Apr 2008

New breakthrough discovery on TB

Medical scientists from the University of Leicester, together with colleagues from St Georges, University of London, funded principally by the Medical Research Council (MRC) and The Wellcome Trust, have published details of a new breakthrough discovery on TB.

1 Apr 2008

Eli Lilly starts trial of treatment of mild to moderate Alzheimer's disease

Eli Lilly and Company has announced the start of a Phase III clinical trial studying LY450139, an investigational gamma secretase inhibitor for the treatment of mild to moderate Alzheimer's disease.

1 Apr 2008

Disappointing resuts for pimecrolimus, investigational anti-restenosis drug

A new medication that researchers had hoped would reduce the risk of arterial renarrowing after stenting has turned in a disappointing performance in a multicenter clinical trial, but the multi-reservoir stent that was used to deliver the drug is still considered promising.

1 Apr 2008

Researchers discover how HIV can hide in cells

Researchers have discovered how Human Immunodeficiency Virus (HIV), which causes AIDS, can hide itself in our cells and dodge the attention of our normal defences, scientists heard at the Society for General Microbiology's 162nd meeting being held this week at the Edinburgh International Conference Centre.

1 Apr 2008

Community-acquired MRSA spreads

Drug resistant hospital superbugs like MRSA have been kept under control in Denmark for more than 30 years.

1 Apr 2008

Chloroform provides clue to 150 year old medical puzzle

One of the earliest general anaesthetics to be used by the medical profession, chloroform, has shed light on a mystery that's puzzled doctors for more than 150 years - how such anaesthetics actually work.

1 Apr 2008

New tool to identify the molecular signatures of serious diseases

University of Florida chemists are the first to use a new tool to identify the molecular signatures of serious diseases - without any previous knowledge of what these microscopic signatures or "biomarkers" should look like.

1 Apr 2008

Superbugs resistant to everything - Doctors running out of treatments

Doctors are running out of treatments for today's trauma victims and critically ill patients because of infections due to drug resistant microbes even after resorting to using medicines thrown out 20 years ago because of severe side effects, scientists heard at the Society for General Microbiology's 162nd meeting being held this week at the Edinburgh International Conference Centre.

1 Apr 2008

Replacing absent microRNAs could make tumors less invasive, more treatable

One group of small, non-coding RNA molecules could serve as a marker to improve cancer staging and may also be able to convert some advanced tumors to more treatable stages, report a University of Chicago-based research team in the April 1, 2008, issue of the journal Genes & Development.

1 Apr 2008

MicroRNAs, EMT and cancer progression

In the April 1 issue of G&D, a research team led by Dr. Marcus Peter (University of Chicago) identifies the microRNA miR-200 as both a powerful indicator and regulator of the epithelial phenotype of cancer cells.

1 Apr 2008

Angina drug ranolazine shows promise for heart rhythm disorders

A recently approved angina drug may also represent a powerful new treatment for a rare hereditary syndrome that places teens at risk for sudden cardiac death, according to research presented at the 57th Annual Scientific Sessions of the American College of Cardiology (ACC) in Chicago.

1 Apr 2008

AIDS, an evolutionary accident?

AIDS, a fatal disease in humans, may partly be the consequence of an evolutionary accident, scientists heard at the Society for General Microbiology's 162nd meeting being held this week at the Edinburgh International Conference Centre.

1 Apr 2008